Bausch Health Cos (NYSE:BHC) Shares Gap Up – Time to Buy?

Bausch Health Cos Inc. (NYSE:BHC) gapped up before the market opened on Monday . The stock had previously closed at $6.35, but opened at $6.60. Bausch Health Cos shares last traded at $7.1550, with a volume of 1,255,990 shares trading hands.

Wall Street Analyst Weigh In

A number of analysts have commented on BHC shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Bausch Health Cos in a report on Wednesday, October 8th. Wall Street Zen upgraded Bausch Health Cos from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 1st. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $9.00.

Bausch Health Cos Stock Up 14.9%

The firm’s fifty day simple moving average is $6.39 and its two-hundred day simple moving average is $6.33. The company has a current ratio of 1.31, a quick ratio of 0.98 and a debt-to-equity ratio of 141.90. The company has a market capitalization of $2.71 billion, a price-to-earnings ratio of 28.06 and a beta of 0.47.

Institutional Investors Weigh In On Bausch Health Cos

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BHC. Tidal Investments LLC increased its position in Bausch Health Cos by 2.6% in the 2nd quarter. Tidal Investments LLC now owns 50,131 shares of the company’s stock valued at $334,000 after acquiring an additional 1,276 shares during the period. CANADA LIFE ASSURANCE Co increased its holdings in shares of Bausch Health Cos by 2.5% in the second quarter. CANADA LIFE ASSURANCE Co now owns 104,156 shares of the company’s stock valued at $690,000 after purchasing an additional 2,552 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of Bausch Health Cos by 65.9% in the second quarter. Russell Investments Group Ltd. now owns 7,819 shares of the company’s stock valued at $51,000 after purchasing an additional 3,106 shares during the period. Bfsg LLC raised its stake in shares of Bausch Health Cos by 32.8% during the third quarter. Bfsg LLC now owns 14,465 shares of the company’s stock worth $93,000 after purchasing an additional 3,570 shares during the last quarter. Finally, State of Wyoming lifted its holdings in shares of Bausch Health Cos by 6.4% during the second quarter. State of Wyoming now owns 63,653 shares of the company’s stock worth $424,000 after purchasing an additional 3,855 shares during the period. Hedge funds and other institutional investors own 78.65% of the company’s stock.

Bausch Health Cos Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.